Bora Pharmaceuticals Co., LTD. (TPE: 6472)

Bora Pharmaceuticals Co., LTD. Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	5,510	3,053	3,281	910.75	669.99	452.68
Short-Term Investments	2,052	342.63	247.62	-	-	30
Trading Asset Securities	-	-	-	-	-	60.01
Cash & Short-Term Investments	7,561	3,396	3,529	910.75	669.99	542.69
Cash Growth	72.70%	-3.77%	287.48%	35.94%	23.46%	2.86%
Accounts Receivable	9,753	4,028	6,120	824.77	539.63	338.33
Other Receivables	916.66	82.61	286.38	33.23	186.77	7.74
Receivables	10,669	4,111	6,407	858.01	726.4	346.07
Inventory	4,984	2,272	1,991	928.64	1,112	297.11
Prepaid Expenses	996.43	186.69	242.47	63.07	51.33	11.95
Other Current Assets	149.68	637.76	71.58	31.87	67.01	48.44
Total Current Assets	24,361	10,603	12,241	2,792	2,627	1,246
Property, Plant & Equipment	11,104	7,493	7,300	4,067	4,158	2,035
Long-Term Investments	222.84	21.26	62.03	-	-	-
Goodwill	2,781	2,781	983.59	-	-	-
Other Intangible Assets	3,074	2,814	1,164	171.05	4.93	18.47
Long-Term Deferred Tax Assets	1,095	1,045	829.64	243.78	37.09	38.13
Other Long-Term Assets	715.78	294.85	181.01	98.65	177.22	44.92
Total Assets	43,353	25,052	22,761	7,372	7,004	3,383
Accounts Payable	782.11	380.45	454.74	235.81	219.06	62.91
Accrued Expenses	1,361	1,022	29.33	321.24	217.8	74.33
Short-Term Debt	7,777	767.51	2,161	645.48	1,218	225
Current Portion of Long-Term Debt	1,277	630.5	725.63	222.09	161.65	75.16
Current Portion of Leases	109.07	106.04	75.31	17.54	18.68	8.6
Current Income Taxes Payable	452.75	987.43	238.65	50.58	18.35	15.25
Current Unearned Revenue	266.63	224.6	85.69	20.47	4.11	4.99
Other Current Liabilities	8,377	4,110	6,725	327.91	428.77	90.81
Total Current Liabilities	20,403	8,229	10,496	1,841	2,286	557.05
Long-Term Debt	8,682	2,724	4,037	1,028	1,158	818.99
Long-Term Leases	765.31	763.33	596.88	305.97	325.37	290.17
Long-Term Unearned Revenue	-	-	4.18	-	-	-
Long-Term Deferred Tax Liabilities	800.09	701.74	742.85	609.77	202.01	60.93
Other Long-Term Liabilities	182.28	753.09	1,608	298.57	413.15	1.74
Total Liabilities	30,969	13,286	17,621	4,220	4,539	1,729
Common Stock	1,016	1,014	753.82	684.12	541.15	394.27
Additional Paid-In Capital	3,385	3,318	1,236	1,026	951.65	676.23
Retained Earnings	5,402	4,729	2,549	1,466	961.01	590.72
Treasury Stock	-438.86	-50.97	-53.09	-	-	-2.4
Comprensive Income & Other	212.48	74.66	42.2	-23.26	10.95	-5.07
Total Common Equity	9,576	9,085	4,528	3,153	2,465	1,654
Minority Interest	2,808	2,681	612.13	-	-	-
Shareholders' Equity	12,384	11,766	5,140	3,153	2,465	1,654
Total Liabilities & Equity	43,353	25,052	22,761	7,372	7,004	3,383
Total Debt	18,610	4,991	7,596	2,219	2,881	1,418
Net Cash (Debt)	-11,049	-1,595	-4,067	-1,308	-2,211	-875.22
Net Cash Per Share	-105.13	-15.40	-41.20	-13.44	-22.91	-9.75
Filing Date Shares Outstanding	100.75	101.12	97.52	97.78	96.42	91.16
Total Common Shares Outstanding	100.75	101.12	97.52	97.78	96.42	91.16
Working Capital	3,958	2,374	1,745	951.22	340.48	689.21
Book Value Per Share	95.05	89.84	46.43	32.24	25.56	18.14
Tangible Book Value	3,721	3,489	2,381	2,981	2,460	1,635
Tangible Book Value Per Share	36.93	34.50	24.41	30.49	25.51	17.94
Land	3,816	3,424	3,397	1,984	2,021	889.81
Buildings	7,405	1,945	1,905	1,393	1,329	719.28
Machinery	4,872	2,506	2,390	859.79	838.14	392.11
Construction In Progress	272.14	115.84	76.72	11.73	-	-
Leasehold Improvements	252.02	251.81	205.29	-	8.1	8.1

Source: S&P Capital IQ. Standard template. Financial Sources.